Neuropharmacology of CNS - PowerPoint PPT Presentation

About This Presentation
Title:

Neuropharmacology of CNS

Description:

Neuropharmacology of CNS & Substance Abuse Story of MPTP (1-methyl-4-phenyl 1,2,3,5-tetrahydropyridine) Monoamine oxidase (MAO) in astrocytes Oxidative phosphorylation – PowerPoint PPT presentation

Number of Views:67
Avg rating:3.0/5.0
Slides: 29
Provided by: lifeNthu3
Category:

less

Transcript and Presenter's Notes

Title: Neuropharmacology of CNS


1
Neuropharmacology of CNS Substance Abuse
  • Story of MPTP (1-methyl-4-phenyl
    1,2,3,5-tetrahydropyridine)
  • Monoamine oxidase (MAO) in astrocytes
  • Oxidative phosphorylation

2
Anatomy of the nervous system
  • Neurons
  • Interstitial cells
  • Astrocytes
  • Oligodendrocytes, Neurolemma, Schwan cells
  • Myelin Sheaths
  • Nodes of Ranvier
  • Anterograde, Retrograde, Microtubules
  • Motor proteins
  • Kinesin, Dynein
  • Microglials, phagocytic cells macrophage/monocyte

3
Morphological considerations
  • Nutritional and biochemical aspects
  • Brain-blood-barrier
  • Tight junctions, Endothelial
  • Anoxic or hypoglycemic

4
The Synapse
  • Three elements Presynaptic, Postsynpatic,
    Synaptic cleft
  • 4 steps 1. synthesis storage 2. transmitter
    release 3. receptor activation 4.
    neurotransmitter inactivation

5
Specific neurotransmitter system
  • Acetylcholine
  • Muscarinic,
  • Nicotinic
  • Glutamate- excitatory
  • AMPA, Kainate, NMDA
  • GABA - inhibitory
  • Subtype A and B
  • Glycine- inhibitory, Spinal cord, strychnine

6
Substance abuse
  • Background
  • main types of abused drugs Table
  • no insulin or penicillin "junkies"

7
Tolerance
  • diminishing drug effect following repeated
    administration. Higher doses are needed to
    produce the same effect.
  • May be pharmacokinetic or pharmacodynamic
    tolerance
  • pharmacokinetic induction of hepatic metabolic
    enzymes e.g. barbiturates
  • pharmacodynamic alteration at receptor levels
    e.g. decrease of GABA receptors followed by
    increase of barbiturate administration morphine
    and its receptor.
  • Tolerance may be developed only one effect of the
    drug but not the others e.g. in opiates,
    euphoric and analgesic effects are tolerated but
    the respiratory depression is not.

8
Cross-tolerance
Cross-tolerance means that individuals tolerant
to one drug will be tolerant to other drugs in
the same class, but not to drugs in other class.
9
Drug dependence
  • signs and symptoms upon withdrawal when drug
    levels fall

10
drug dependence with opiates
1. opiates inhibits the firing of locus ceruleus
(LC) neurons by interacting with m receptors. 2.
long term opiate administration causes molecular
adaptations in the signaling properties of
neurons. 3. decrease signaling without
decreasing the numbers or affinity of the
receptors. 4. cAMP cascade is up-regulated,
?phosphorylation of a slow depolarizing Na
channel, ?neuronal excitability. 5.
hyper-excitable state becomes manifested when
withdrawn
11
  • withdrawal symptoms vary with drugs.
    barbiturates, alcohol, possible death
  • cross-dependence drug A that show
    cross-tolerance with drug B of the same class
    also support the dependence of B .

12
Caffeine
  • competitive antagoinst of adenosine receptors
  • sedative
  • caffeine is an addicting drug because it shows
    reinforcement and its withdrawal induces
    symptoms headache, drowsiness, fatigue,
    decreased performance, depression

13
Methadone maintenance
  • opiate agonist, analgesic, to replace the
    addict's heroine
  • maintenance basis (same dose, chronic use),
    withdrawal basis (gradually reducing dose, 1-6
    months)

14
  • cocaine,
  • HCl, freebase, crack, 1-2 min peak CNS effects
  • dopamine receptor agonists

15
Addiction Liability
  • animal behavior paradigm self-administer
  • Table of Addiction risk of major psychoactive
    drugs
  • reward pathway center, dopaminergic neurons
    ventral tegmental area forebrain,
  • euphoria reinforcement cycle

16
War on drugs
  • a perceived threat, moral principle
  • Table. Number of yearly drug-related deaths
  • Tobacco, Alcohol gtgt Cocaine, Heroine, Aspirin

17
Descriminalization
  • Netherlands, soft and hard drugs coffee shop 4.6
    use cannabis vs 4.8 in U.S.

18
Drugs in Sports
  • Background
  • not drug abuse but illicit use of banned
    substances
  • History
  • Scandinavian warriors, muscarine, psychoactive
    alkaloids
  • 1800s amphetamine, strychnine and ephedrine
    commercially available
  • IOC ban (1) substances of selected groups (2)
    doping methods.
  • rationales clearly enhanced performance,
    medical safety, social acceptability

19
Stimulants
  • amphetamine, cocaine and strychnine
  • delay onset of fatigue
  • caffeine, phenylpropanolamine, ephedrine
  • problem for legitimate health medication
  • Rick DeMont episode
  • alternatives salbutamol terbutalin by inhaler
    only

20
Narcotics
  • morphine, pain killers, alternative
  • OTC cold cough remedies contain dextromethorphan

21
Anabolic agents
  • anabolic androgenic steroids (AAS) testosterone
    and its derivatives
  • treatment bone marrow failure anemias
  • moderately high dose ? gain 13 lbs pure muscle
  • side effects females masculinization low vocie
  • use of AAS in international sports competitions
  • urine test testosteroneepitestosterone TE ratio
  • b-2 agonist asthma relief clenbuterol
  • livestock industry growth promote
  • drug treated meat
  • Alekey Petrov story

22
Diuretics
  • urine excretion conceal evidence of the misuse of
    drugs
  • rapid weight loss
  • weight classes boxing wrestling
  • masking agents probenecid prevent secretion of
    AAS
  • epitestosterone TE ratio
  • absolute level no more than 200 ng/ml

23
Miscellaneous drugs
  • b-blockers, ? blood pressure
  • cardiac output, hypertension, cardiac
    arrythmia, angina
  • shooting archery
  • chorionic gonadotropin ? androgenic steorids
  • testosterone ?
  • corticotropin (adrenal stimulatory trophic
    hormone) corticosteroids
  • erythropoetin (EPO) red blood cell production
    blood samples

24
Blood doping
  • oxygen-carrying capacity
  • technique
  • withdrawing 1 liter blood, store frozen 9-12
    weeks
  • hemoglobin return, reintroduce

25
???
??????????????????????, ????MDMA(3,4-methylenediox
y-methamphetamine)?Ecstasy. ?????1914?,?????(E.
Merk)??????????, ???????????????????????? ??,?????
???1980?,??FDA????, ????????,????????????? ??1983
??,?????????????????? ??????1985?,??????? ???1990?
??????????, ?????????,????????? ??????????????????
MDMA???, ??????????????????????????????????
26
Flunitrazepam (FM2)
commonly abused benzodiazepines drugs such as
Flunitrazepam (FM2), Diazepam (Valium),
Triazolam (Halcion), Lorazepam, and Oxazepam
27
RU468 abortion drug, anti-progesterone effect
28
  • ????????????...
  • ? ?
  • ??????????????
  • ??????Methaqualone(Mandrax)????,????????????
  • ??????
  • ????????????????????????????
  • ????????,?????????????,????????,?????????????????
    ???????????????????????????,?????????????????????
    ????????????????????????,???????????????????,?????
    ????????????????????????????????????????
Write a Comment
User Comments (0)
About PowerShow.com